Brooks Laboratories Limited (NSE:BROOKS)

India flag India · Delayed Price · Currency is INR
66.68
-1.32 (-1.94%)
Jun 19, 2026, 3:28 PM IST
Market Cap1.96B -54.0%
Revenue (ttm)857.38M +3.9%
Net Income245.84M
EPS8.35
Shares Out 29.46M
PE Ratio7.99
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,640
Open67.99
Previous Close68.00
Day's Range66.50 - 68.10
52-Week Range36.30 - 164.02
Beta1.11
AnalystsStrong Buy
Price Target53.00 (-20.52%)
Earnings DateMay 29, 2026

About Brooks Laboratories

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company’s product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and dry powder injections; formulations for antibiotics, pain management, and controlled drugs; and oncology products and hormonal injections, etc. It also ... [Read more]

Sector Healthcare
Founded 2002
Employees 323
Stock Exchange National Stock Exchange of India
Ticker Symbol BROOKS
Full Company Profile

Financial Performance

Financial Statements